in Newswire November 9, 2016

Mylan Pharmaceuticals Hit with Another Class Action Over EpiPen Prices

by Corrado Rizzi

Last Updated on November 9, 2016

Corcoran et al v. Mylan Pharmaceuticals Inc. et al

Filed: November 9, 2016 § 4:16-cv-05983-JSW

A new class action out of California against Mylan Pharmaceuticals and Mylan Specialty L.P. claims the companies illegally inflated the cost of its flagship EpiPen.


Mylan, Inc.




Last Updated on November 9, 2016 — 4:11 PM

Corrado Rizzi

Corrado Rizzi is the Managing Editor and a writer for

About is a group of online professionals (designers, developers and writers) with years of experience in the legal industry.

Learn More

Before commenting, please review our comment policy.